Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

Forecasting drug utilization and expenditure in a metropolitan health region.

Wettermark B, Persson ME, Wilking N, Kalin M, Korkmaz S, Hjemdahl P, Godman B, Petzold M, Gustafsson LL; Regional Drug Expert Consortium in Stockholm County Council.

BMC Health Serv Res. 2010 May 17;10:128. doi: 10.1186/1472-6963-10-128.

PMID:
20478043
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance.

Godman B, Wettermark B, Hoffmann M, Andersson K, Haycox A, Gustafsson LL.

Expert Rev Pharmacoecon Outcomes Res. 2009 Feb;9(1):65-83. doi: 10.1586/14737167.9.1.65. Review.

PMID:
19371180
[PubMed - indexed for MEDLINE]
3.

Using aggregate data on dispensed drugs to evaluate the quality of prescribing in urban primary health care in Sweden.

Wettermark B, Bergman U, Krakau I.

Public Health. 2006 May;120(5):451-61. Epub 2006 Feb 28.

PMID:
16513149
[PubMed - indexed for MEDLINE]
4.

Projecting future drug expenditures--2012.

Hoffman JM, Li E, Doloresco F, Matusiak L, Hunkler RJ, Shah ND, Vermeulen LC, Schumock GT.

Am J Health Syst Pharm. 2012 Mar 1;69(5):405-21. doi: 10.2146/ajhp110697. Erratum in: Am J Health Syst Pharm. 2012 Oct 1;69(19):1620.

PMID:
22345420
[PubMed - indexed for MEDLINE]
5.

Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe.

Wettermark B, Godman B, Andersson K, Gustafsson LL, Haycox A, Bertele V.

Pharmacoeconomics. 2008;26(7):537-50. Review.

PMID:
18563945
[PubMed - indexed for MEDLINE]
6.

Estimating the budget impact of orphan medicines in Europe: 2010 - 2020.

Schey C, Milanova T, Hutchings A.

Orphanet J Rare Dis. 2011 Sep 27;6:62. doi: 10.1186/1750-1172-6-62.

PMID:
21951518
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Spending on medicines in Israel in an international context.

Sax P.

Isr Med Assoc J. 2005 May;7(5):286-91.

PMID:
15909459
[PubMed - indexed for MEDLINE]
Free Article
8.

Projecting future drug expenditures in U.S. nonfederal hospitals and clinics--2013.

Hoffman JM, Li E, Doloresco F, Matusiak L, Hunkler RJ, Shah ND, Vermeulen LC, Schumock GT.

Am J Health Syst Pharm. 2013 Mar 15;70(6):525-39. doi: 10.2146/ajhp120759.

PMID:
23456407
[PubMed - indexed for MEDLINE]
9.
10.

Projecting future drug expenditures--2010.

Hoffman JM, Doloresco F, Vermeulen LC, Shah ND, Matusiak L, Hunkler RJ, Schumock GT.

Am J Health Syst Pharm. 2010 Jun 1;67(11):919-28. doi: 10.2146/ajhp100068.

PMID:
20484216
[PubMed - indexed for MEDLINE]
11.

The impact of population ageing on future Danish drug expenditure.

Kildemoes HW, Christiansen T, Gyrd-Hansen D, Kristiansen IS, Andersen M.

Health Policy. 2006 Feb;75(3):298-311. Epub 2005 Apr 22.

PMID:
16399170
[PubMed - indexed for MEDLINE]
12.

Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals.

Andersson K, Bergström G, Petzold MG, Carlsten A.

Health Policy. 2007 May;81(2-3):376-84. Epub 2006 Sep 1.

PMID:
16945449
[PubMed - indexed for MEDLINE]
13.

Prescription drugs: issues of cost, coverage, and quality.

Copeland C.

EBRI Issue Brief. 1999 Apr;(208):1-21.

PMID:
10539445
[PubMed - indexed for MEDLINE]
14.
15.

Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.

Martin BI, Turner JA, Mirza SK, Lee MJ, Comstock BA, Deyo RA.

Spine (Phila Pa 1976). 2009 Sep 1;34(19):2077-84. doi: 10.1097/BRS.0b013e3181b1fad1.

PMID:
19675510
[PubMed - indexed for MEDLINE]
16.

Projecting future drug expenditures--2001.

Mehl B, Santell J.

Am J Health Syst Pharm. 2001 Jan 15;58(2):125-33. Review.

PMID:
11202535
[PubMed - indexed for MEDLINE]
17.

Physician and patient characteristics associated with prescriptions and costs of drugs in the Lazio region of Italy.

Orzella L, Chini F, Giorgi Rossi P, Borgia P.

Health Policy. 2010 May;95(2-3):236-44. doi: 10.1016/j.healthpol.2009.12.005. Epub 2010 Jan 4.

PMID:
20047773
[PubMed - indexed for MEDLINE]
18.

Projecting future drug expenditures--1996.

Santell JP.

Am J Health Syst Pharm. 1996 Jan 15;53(2):139-50.

PMID:
8653479
[PubMed - indexed for MEDLINE]
19.

The drug budget silo mentality: the French case.

Le Pen C.

Value Health. 2003 Jul-Aug;6 Suppl 1:S10-9.

PMID:
12846922
[PubMed - indexed for MEDLINE]
20.

Projecting future drug expenditures--2009.

Hoffman JM, Shah ND, Vermeulen LC, Doloresco F, Martin PK, Blake S, Matusiak L, Hunkler RJ, Schumock GT.

Am J Health Syst Pharm. 2009 Feb 1;66(3):237-57. doi: 10.2146/ajhp080636.

PMID:
19179637
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk